687 related articles for article (PubMed ID: 26427884)
1. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
2. Developmental role of nuclear factor E2-related factor 2 in mitigating methamphetamine fetal toxicity and postnatal neurodevelopmental deficits.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2013 Dec; 65():620-631. PubMed ID: 23932974
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Liu Q; Hazan A; Grinman E; Angulo JA
Brain Res; 2017 Mar; 1659():148-155. PubMed ID: 28130052
[TBL] [Abstract][Full Text] [Related]
4. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Achat-Mendes C; Anderson KL; Itzhak Y
Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.
Granado N; Lastres-Becker I; Ares-Santos S; Oliva I; Martin E; Cuadrado A; Moratalla R
Glia; 2011 Dec; 59(12):1850-63. PubMed ID: 21882243
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
8. Lactulose attenuates METH-induced neurotoxicity by alleviating the impaired autophagy, stabilizing the perturbed antioxidant system and suppressing apoptosis in rat striatum.
Xie XL; He JT; Wang ZT; Xiao HQ; Zhou WT; Du SH; Xue Y; Wang Q
Toxicol Lett; 2018 Jun; 289():107-113. PubMed ID: 29550550
[TBL] [Abstract][Full Text] [Related]
9. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
10. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Miller DB; O'Callaghan JP; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
Bowyer JF; Robinson B; Ali S; Schmued LC
Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
[TBL] [Abstract][Full Text] [Related]
12. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits.
Jeng W; Wong AW; Ting-A-Kee R; Wells PG
Free Radic Biol Med; 2005 Aug; 39(3):317-26. PubMed ID: 15993330
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
15. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
16. Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia.
Imam SZ; Ali SF
J Neurochem; 2001 Sep; 78(5):952-9. PubMed ID: 11553669
[TBL] [Abstract][Full Text] [Related]
17. Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.
Granado N; Ares-Santos S; Tizabi Y; Moratalla R
Neurotox Res; 2018 Oct; 34(3):627-639. PubMed ID: 29934756
[TBL] [Abstract][Full Text] [Related]
18. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
19. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
20. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Sriram K; Miller DB; O'Callaghan JP
J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
